Learn More
Medchemexpress LLC Tolazamide | 1156-19-0 | 99.9% | 25 MG

Supplier: Medchemexpress LLC 25MGHYB0920
Tolazamide is an orally active sulfonylurea agent that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel. It has anti-diabetic properties, lowering blood glucose and decreasing insulin dose while maintaining adequate metabolic control. Tolazamide is able to improve or normalize hyperglycemia and HbA.
- Inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel.
- Possesses anti-diabetic properties.
- Lowers blood glucose.
- Decreases insulin dose while maintaining adequate metabolic control.
- Improves or normalizes hyperglycemia and HbA.
- Attenuates gluconeogenesis and ketogenesis in preclinical studies.
- Soluble in DMSO (≥ 39 mg/mL).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.